SLC16A4 and metastatic malignant neoplasm in the lymph nodes: Moreover, the expression of SLC16A4 was closely associated with the clinical pathological features of lung cancer patients, including gender, tumor invasion depth, lymph node metastasis, tumor stage, and smoking history.